Engel Law PLLC is investigating whether fair value to Syneos Health, Inc. (NASDAQ: SYNH) shareholders will result from the proposed acquisition of Syneos by a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital, for $43.00 per share in cash for each Syneos share.
The Firm’s investigation concerns:
(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.